Jobs Gains Don't Ease Spending Strains

Related Link: 

An improving job market is giving Americans the wherewithal to keep buying more. But things aren’t so good that spending is about to really rip.

U.S. Antitrust Cops Raise Their Game

Related Link: 

Corporate deal making is at an eight-year high at the same time the Obama administration’s antitrust enforcers are on their strongest footing ever, setting up a tug-of-war over industry consolidation.

Tesla's Second Quarter Deliveries Surge 52%

Related Link: 

Tesla Motors delivered 11,507 Model S electric sedans in the second quarter of the year, a 52% increase over the prior-year period and a pace that far exceeds electric-car sales by rivals.

Univision Puts IPO Plans in Motion

Related Link: 

Univision, owner of the dominant Spanish-language broadcaster in the U.S., kicked off the process to go public, as it seeks to attract investors to its influential Hispanic base amid seismic digital shifts that are reshaping the television industry.

Aetna Nears Deal to Buy Humana

Related Link: 

Aetna is nearing a deal to buy Humana, according to people familiar with the matter, in a tie-up of health insurers that could be announced this week.

BP to Pay $18.7 Billion to Settle Deepwater Horizon Spill Claims

Related Link: 

BP agreed to pay $18.7 billion over 18 years to settle all federal and state claims arising from 2010’s Deepwater Horizon oil spill, including the biggest pollution penalty in U.S. history.

Barnes & Noble Names Boire as CEO of Retail Business

Related Link: 

Barnes & Noble Inc. named Sears Canada Chief Executive Ronald Boire to lead its retail business as the company readies for a spinoff of its college stores.

Airlines' New Normal: More Seats, Fewer Flights

Related Link: 

Using an industry technique known as “upgauging,” airlines increase capacity by adding seats on existing jets and replacing smaller planes with larger ones.

BBC to Cut Over 1,000 Jobs

Related Link: 

The British Broadcasting Corp., the U.K.’s venerable state-funded broadcaster, said Thursday it is cutting more than 1,000 jobs to cope with the increasing migration of television viewers to the Internet.

Vertex's $259,000 Cystic Fibrosis Drug Approved

Related Link: 

Vertex’s cystic-fibrosis drug Orkambi, which treats the most common mutation of the disease, received U.S. regulatory approval on Thursday.

Syndicate content